CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Influenza A(H3N2)v laboratory detection questionnaire results
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, ECDC and the Community Network of Reference Laboratories (CNRL) disseminated a questionnaire to explore the RT-PCR capability of influenza reference laboratories in EU/EEA countries to detect A(H3N2)v viruses in their day-to-day diagnostics and to subtype them as swine-origin variant viruses.
Survey of National Reference Laboratory capacity for six FWD in EU/EEA countries
In 2009, a survey was conducted to form a picture of the availability and scope of services offered by National Reference Laboratories in EU and EEA countries with respect to six priority food and waterborne pathogens: Campylobacter, Listeria, Salmonella, Shigella, Shiga toxin/verotoxin–producing Escherichia coli (STEC/VTEC) and Yersinia.
STI laboratory diagnostics in Europe
This survey was designed to collect information on the laboratory diagnosis of gonorrhoea, chlamydia and syphilis; clinical reporting; laboratory capacity for testing; laboratory accreditation and external quality assessment (EQA); training; reporting and laboratory systems.
EU Laboratory Capability Monitoring System (EULabCap) - Report on 2013 survey of EU/EEA country capabilities and capacities
This first report on 2013 data presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.
EU Laboratory Capability Monitoring System (EULabCap): Report on 2014 survey of EU/EEA country capabilities and capacities
This second EULabCap report, on 2014 data presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.
About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
Public Health Microbiology Programme
Microbiology laboratories provide a first line of defence against health threats from communicable diseases and antimicrobial resistance. The ECDC provides scientific advice, capacity building activities and operational support to foster capable and responsive public health microbiology services for the European Union and beyond.